av/dbv-technologies--big.svg

NASDAQ:DBVT

DBV Technologies

  • Stock

1.51

−4.78%

−0.08

USD last updated 27/07 01:51:33

Last Close

1.59

02/05 08:36

Market Cap

73.81M

Beta: 1.26

Volume Today

566.50K

Avg: 37.63K

PE Ratio

−0.68

PFCF: −2.41

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced co...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.50.52019-08-012020-06-302021-08-022023-03-022024-07-29

    Revenue (Estimate*)

    5M10M2019-08-012020-06-302021-08-022023-03-022024-07-29

    *Estimate based on analyst consensus